Literature DB >> 12749384

Expression of cyclooxygenase-2 in embryonic and fetal tissues during organogenesis and late pregnancy.

K M Stanfield1, R R Bell, A R Lisowski, M L English, S S Saldeen, K Nasir M Khan.   

Abstract

BACKGROUND: Cyclooxygenase (COX) catalyzes the committed step in prostaglandin biosynthesis and exists as two related but unique isoforms, COX-1 (constitutive) and COX-2 (inducible). Prostaglandins (PGs) are known to have many important functions in reproduction, such as placentation and decidualization. Studies with the COX-1 and COX-2 knockout mice have demonstrated that COX-2, but not COX-1, is crucial for normal ovulation, implantation, and decidualization, suggesting that COX-2-derived PGs are important during the initial stages of pregnancy. Although the COX-2 knockout mice did not exhibit any abnormalities at birth, relatively little information exists with regard to the expression of COX-2 in the fetus during development.
METHODS: In order to understand the role of COX-2 throughout pregnancy, we characterized the cell type and the temporal expression of inducible COX-2 throughout embryonic and fetal development in the rat (n = 22) by immunohistochemistry and in situ hybridization.
RESULTS: High levels of COX-2 expression were seen in decidualized uterine tissue on gestation days 7-13 and then in the fetal membranes on gestation days 17-20. Cyclooxygenase-2 expression was not detectable in any tissues from developing embryos during gestation days 7-13, but was observed in the fetal growth period (gestation days 15-20) in the skin, heart, cartilage, and the kidney.
CONCLUSIONS: No COX-2 expression was seen in fetal tissues at days 7-13 of gestation, but was seen in various tissues at days 15-17 of gestation. These observations suggest that COX-2 may be important in mid to late pregnancy through an effect on fetal organ growth, but not in the organogenetic phase of fetal development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749384     DOI: 10.1002/bdra.10032

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  11 in total

Review 1.  [Prostaglandin E₂: innovative approaches for tissue engineering of articular cartilage].

Authors:  C Brochhausen-Delius
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  Embryonic expression of cyclooxygenase-2 causes malformations in axial skeleton.

Authors:  Minsub Shim; Julie Foley; Colleen Anna; Yuji Mishina; Thomas Eling
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

3.  Prenatal Activation of Glucocorticoid Receptors Induces Memory Impairment in a Sex-Dependent Manner: Role of Cyclooxygenase-2.

Authors:  Mai Abul; Maie Dawoud Al-Bader; Abdeslam Mouihate
Journal:  Mol Neurobiol       Date:  2022-04-09       Impact factor: 5.590

4.  Novel allelic variants in the canine cyclooxgenase-2 (Cox-2) promoter are associated with renal dysplasia in dogs.

Authors:  Mary H Whiteley; Jerold S Bell; Debby A Rothman
Journal:  PLoS One       Date:  2011-02-08       Impact factor: 3.240

5.  Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study.

Authors:  Marleen M H J van Gelder; Nel Roeleveld; Hedvig Nordeng
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

6.  Anti-inflammatory and immunosuppressive drugs and reproduction.

Authors:  Monika Østensen; Munther Khamashta; Michael Lockshin; Ann Parke; Antonio Brucato; Howard Carp; Andrea Doria; Raj Rai; Pierluigi Meroni; Irene Cetin; Ronald Derksen; Ware Branch; Mario Motta; Caroline Gordon; Guillermo Ruiz-Irastorza; Arsenio Spinillo; Deborah Friedman; Rolando Cimaz; Andrew Czeizel; Jean Charles Piette; Ricard Cervera; Roger A Levy; Maurizio Clementi; Sara De Carolis; Michelle Petri; Yehuda Shoenfeld; David Faden; Guido Valesini; Angela Tincani
Journal:  Arthritis Res Ther       Date:  2006-05-11       Impact factor: 5.156

Review 7.  Effects of NSAIDs on the Inner Ear: Possible Involvement in Cochlear Protection.

Authors:  Tomofumi Hoshino; Keiji Tabuchi; Akira Hara
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-27

8.  Pulmonary and cardiorenal cyclooxygenase-1 (COX-1), -2 (COX-2), and microsomal prostaglandin E synthase-1 (mPGES-1) and -2 (mPGES-2) expression in a hypertension model.

Authors:  Zaher A Radi; Robert Ostroski
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

9.  Gestation Related Gene Expression of the Endocannabinoid Pathway in Rat Placenta.

Authors:  Kanchan Vaswani; Hsiu-Wen Chan; Hassendrini N Peiris; Marloes Dekker Nitert; Ryan J Wood Bradley; James A Armitage; Gregory E Rice; Murray D Mitchell
Journal:  Mediators Inflamm       Date:  2015-07-02       Impact factor: 4.711

10.  Allelic variation in the canine Cox-2 promoter causes hypermethylation of the canine Cox-2 promoter in clinical cases of renal dysplasia.

Authors:  Mary H Whiteley
Journal:  Clin Epigenetics       Date:  2014-04-03       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.